Taro Provides Results for December 31, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Taro Pharma (TARO) Reports Q3 EPS of $4.41
February 10, 2016 5:16 PM ESTTaro Pharma (NYSE: TARO) reported Q3 EPS of $4.41, versus $3.33 reported last year. Revenue for the quarter came in at $258.3 million, versus $237.7 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
... More


